CD34 and neoplasm: A variety of sources of hematopoietic stem cells have been used for developing humanized mice, including CD34+ cells expanded from umbilical cord blood or bone marrow, CD34+ cells expanded from the peripheral blood of the patient, or T cells isolated from the peripheral blood of the patient whose tumor is engrafted into mice bearing the PDX.